Australia markets closed

Novo Nordisk A/S (NONOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
123.50-3.30 (-2.60%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 554.71B
Enterprise value 554.25B
Trailing P/E 46.23
Forward P/E 37.45
PEG ratio (5-yr expected) 2.39
Price/sales (ttm)16.66
Price/book (mrq)36.04
Enterprise value/revenue 2.39
Enterprise value/EBITDA 4.84

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 348.35%
S&P500 52-week change 321.08%
52-week high 3140.32
52-week low 374.70
50-day moving average 3126.39
200-day moving average 3104.60

Share statistics

Avg vol (3-month) 342.55k
Avg vol (10-day) 314.42k
Shares outstanding 53.39B
Implied shares outstanding 64.49B
Float 83.19B
% held by insiders 15.98%
% held by institutions 136.87%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.86
Forward annual dividend yield 41.51%
Trailing annual dividend rate 39.40
Trailing annual dividend yield 37.41%
5-year average dividend yield 41.45
Payout ratio 438.00%
Dividend date 320 Aug 2019
Ex-dividend date 422 Mar 2024
Last split factor 22:1
Last split date 313 Sept 2023

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 36.03%
Operating margin (ttm)42.79%

Management effectiveness

Return on assets (ttm)23.39%
Return on equity (ttm)88.07%

Income statement

Revenue (ttm)232.26B
Revenue per share (ttm)51.81
Quarterly revenue growth (yoy)37.00%
Gross profit (ttm)N/A
EBITDA 109.81B
Net income avi to common (ttm)83.68B
Diluted EPS (ttm)2.67
Quarterly earnings growth (yoy)61.60%

Balance sheet

Total cash (mrq)30.23B
Total cash per share (mrq)6.78
Total debt (mrq)27.01B
Total debt/equity (mrq)25.34%
Current ratio (mrq)0.82
Book value per share (mrq)23.90

Cash flow statement

Operating cash flow (ttm)108.91B
Levered free cash flow (ttm)54.1B